(Bloomberg) -- Iceland is joining its Nordic peers in halting inoculations with Moderna Inc.’s Spikevax shot on concern over side effects.
The Moderna jab, which has mostly been used in Iceland for second doses, won’t be used until more information over its safety has been collected, the chief epidemiologist said on Friday.
Sweden, Denmark and Finland have this week suspended the jabs for younger people because of the risk of heart inflammation as a potential side effect. Norway said men under 30 should consider choosing the Pfizer Inc.’s and BioNTech SE’s rival vaccine, and the other Nordic nations also recommended that as an alternative. Both vaccinations use messenger RNA technology to prompt an immune reaction.
©2021 Bloomberg L.P.
BNN Bloomberg Picks
Disney+ sees Beatles bump after release of Fab Four documentary
Turkeys expected to be pricier, harder to find this Christmas
Nissan unveils US$18B electric-vehicle strategy
Virgil Abloh, fashion’s most powerful Black exec, dies at 41
How active is your passive investment manager (and vice versa)?
‘Huge validation’: Why Crypto.com is putting its name on the L.A. Lakers’ arena